Comparison of Ten Surrogate Insulin Resistance and Obesity Markers to Identify Metabolic Syndrome in Mexican Adults
2024
Iván Filiberto Contreras-Hernández | Cruz Vargas-De-León | Luis Rey García-Cortes | Adriana Flores-Miranda | Rodrigo Romero-Nava | María Esther Ocharán-Hernández
Metabolic syndrome (<i>MetS</i>) is a group of clinical traits directly linked to type 2 diabetes mellitus and cardiovascular diseases, whose prevalence has been rising nationally and internationally. We aimed to evaluate ten known and novel surrogate markers of insulin resistance and obesity to identify <i>MetS</i> in Mexican adults. The present cross-sectional study analyzed 10575 participants from ENSANUT-2018. The diagnosis of <i>MetS</i> was based on the Adult Treatment Panel III (ATP III) criteria and International Diabetes Federation (IDF) criteria, stratified by sex and age group. According to ATP III, the best biomarker was the metabolic score for insulin resistance (METS-IR) in men aged 20–39 and 40–59 years and lipid accumulation product (LAP) in those aged ≥60 years. The best biomarker was LAP in women aged 20–39 and triglyceride–glucose index (TyG) in those aged 40–59 and ≥60 years. Using the IDF criteria, the best biomarker was LAP in men of all ages. TyG gave the best results in women of all ages. The best biomarker for diagnosis of <i>MetS</i> in Mexican adults depends on the criteria, including sex and age group. LAP and TyG are easy to obtain, inexpensive, and especially useful at the primary care level.
Показать больше [+] Меньше [-]Ключевые слова АГРОВОК
Библиографическая информация
Эту запись предоставил Directory of Open Access Journals